Purinergic activation of a tyrosine kinase-dependent pathway in cardiac cells

Authors
Citation
M. Puceat, Purinergic activation of a tyrosine kinase-dependent pathway in cardiac cells, DRUG DEV R, 45(3-4), 1998, pp. 427-433
Citations number
49
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG DEVELOPMENT RESEARCH
ISSN journal
02724391 → ACNP
Volume
45
Issue
3-4
Year of publication
1998
Pages
427 - 433
Database
ISI
SICI code
0272-4391(199811/12)45:3-4<427:PAOATK>2.0.ZU;2-K
Abstract
This overview focuses on the role of cytosoluble tyrosine kinases in the pu rinergic regulation of cardiac function. Cardiac cells express many cytosol ic tyrosine kinases, including pp60(c-src), p59(c-fyn) Csk, FAK, and Tec. P urinergic stimulation of cardiomyocytes increases the activity of pp60(c-sr c) and p59(c-fyn) and induces phosphorylation of FAK. This signaling pathwa y leads to phosphorylation of many proteins, including PLC gamma, the major PLC isoform in heart, and AE1, the predominant cardiac Cl/HCO3 exchanger. Tyrosine kinase-mediated phosphorylation of PLC gamma and AE1 allows the ca rdiomyocyte to regulate both its Ca2+ and H+ homeostasis, respectively. The existence of other cardiac intracellular substrates of tyrosine kinases, t argets of the purinergic stimulation as well as the physiological relevance of this signaling pathway, is discussed. Drug Dev. Res. 45:427-433, 1998. (C) 1998 Wiley-Liss, Inc.